$ECL

Doukeris Michel D purchased $2.0M of ECL

Doukeris Michel D purchased 7,750 shares of ECOLAB INC. (ECL) at $258.00 ($2.00M total) on 2026-06-10.

Original reporting
SEC EDGAR · Doukeris Michel D
Published Jun 11, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECL
Bullish
medium confidence
Mentioned
$ECL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECLBullishLow
01

Why it matters

A director’s open-market purchase of ~$2.0M may slightly improve perceived alignment with shareholders, but it does not change fundamentals without corroborating news.

02

Market read

Traders may treat this as a small sentiment input rather than a tradable fundamental catalyst.

03

What to watch

No 10b5-1 plan is cited; however, the article provides no context on prior trading patterns or whether the buy was part of a broader strategy.

Relevance 7/10Novelty 8/10Timing: Filed 2026-06-11; transaction dated 2026-06-10

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Ecolab.

Company-level read

Ticker impact

$ECLBullishMedium confidence
Context

Ecolab director Doukeris Michel D bought 7,750 shares in an open-market transaction worth about $2.0M, disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; any effect should be small unless accompanied by other company-specific news.

Evidence & confidence

The filing is a primary-source insider transaction, but it does not include new operational guidance, contracts, or regulatory outcomes.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (e.g., diversification or personal liquidity planning) and may not reflect near-term business changes.

Key entities

  • ECOLAB INC.

    Subject of the Form 4 insider transaction disclosure.

  • Doukeris Michel D

    Director who purchased 7,750 shares on 2026-06-10.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECLMedAI 8/10

Ecolab Inc (ECL) (Q3 2026) Earnings Call Highlights: 7% Organic Sales Growth, 63%

Ecolab Inc (ECL) reported 7% organic sales growth in Q3 2026, with High-Tech segment growing 63%. Challenges include North American restaurant traffic decline, commodity cost inflation, and a 1% growth headwind from the Middle East. CoolIT acquisition is expected to impact EPS. CEO Christophe Beck reaffirmed 2027 margin targets and growth expectations, citing strong demand in High-Tech and Life Sciences.

$ECLMed

Ecolab (ECL) Q3 2026 Earnings Call Transcript

Ecolab (ECL) reported Q3 2026 pro forma sales growth of high single digits and adjusted EPS growth of mid-teens. The company highlighted strong performance in Food & Beverage, Life Sciences, and Global High-Tech, with organic sales growth of 8%, 17%, and 63% respectively. Ecolab also emphasized its One Ecolab model, which integrates water, hygiene, and digital solutions to drive customer value and growth. The company plans to expand field sales and service offerings to accelerate growth further.

$ECLMedAI 8/10

Ecolab Q3 Earnings Call Highlights

Ecolab (ECL) reported Q3 growth in Life Sciences (17%), Ecolab Digital (34%), and Pest Elimination (8%). Global High-Tech saw 63% growth, driven by data-center cooling and water systems. Ecolab expects 2027 organic sales growth at the upper end of its 5%-7% target range and adjusted operating-income margin of 20%. The company is integrating recent acquisitions and reducing leverage.

$ECLHighAI 8/10

Ecolab Q3 2026 slides: organic growth accelerates to 7%, margins expand

Ecolab (ECL) reported Q3 2026 results with 7% organic sales growth, 13% total sales growth, and adjusted EPS of $2.18, slightly above estimates. Revenue was $4.69B, below consensus. Stock rose 1.29% premarket. High-growth segments like Global High-Tech and Life Sciences drove performance. Management expects full-year EPS of $8.10-$8.20 and 2027 margin target of 20%.

$ECLMedAI 8/10

Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y

Ecolab reported Q3 2026 adjusted earnings of $2.18 per share, up 5% Y/Y, matching estimates. Revenues rose 13% to $4.69B, beating estimates. Organic sales increased 7%, with strong demand in Global High-Tech and Life Sciences. ECL raised its 2026 adjusted earnings outlook to $8.10-$8.20 per share, citing acquisitions and pricing gains.